Cell-Free DNA Blood Collection Tubes: Capturing the Molecular Signature of Disease with Unparalleled Precision

In the realm of precision medicine, cell-free DNA (cfDNA) has emerged as a transformative biomarker, offering a non-invasive window into the molecular landscape of disease. Circulating in the bloodstream, cfDNA fragments shed from tumor cells and other tissues hold invaluable diagnostic and prognostic information.

Cell-Free DNA Blood Collection Tubes are meticulously designed to capture and preserve the integrity of cfDNA molecules, ensuring the accuracy and reliability of downstream analyses. These specialized tubes feature a unique anticoagulant and preservative solution that effectively inhibits nuclease activity, preventing cfDNA degradation and ensuring its stability for extended periods.

Key Features and Benefits:

• Unmatched cfDNA Capture and Stability: The proprietary anticoagulant and preservative solution effectively stabilizes cfDNA molecules, preventing degradation and ensuring their availability for downstream analyses.
• Enhanced Sample Integrity: The tubes' inert materials and sterile manufacturing process safeguard the integrity of blood samples, minimizing contamination and preserving the native cellular and molecular composition.
• Ease of Use and Compatibility: The tubes are designed for user-friendly collection and processing, compatible with a wide range of downstream cfDNA extraction and analysis methods.

Expanding the Horizons of Precision Medicine:

Cell-Free DNA Blood Collection Tubes empower researchers and clinicians to harness the power of cfDNA for a diverse range of applications, including:

• Early cancer detection and monitoring: CfDNA analysis can detect and monitor cancer at its early stages, enabling timely interventions and improved patient outcomes.
• Non-invasive disease monitoring: cfDNA can provide insights into disease progression, treatment efficacy, and recurrence risk, facilitating personalized treatment strategies.
• Stratification of patient populations: CfDNA profiling can guide patient stratification, ensuring the selection of optimal treatment regimens based on molecular characteristics.

Advancing Clinical Care with cfDNA:

Cell-Free DNA Blood Collection Tubes revolutionize cfDNA isolation and preservation, empowering precision medicine to reach new heights. By providing a reliable source of high-quality cfDNA, these tubes contribute to the development of innovative diagnostic tools and personalized treatment approaches, ultimately improving patient care and outcomes.

Embrace the Power of cfDNA for Precision Medicine:

With Cell-Free DNA Blood Collection Tubes, you can:

• Capture and preserve cfDNA with unparalleled precision
• Enable reliable downstream analyses for accurate disease detection and monitoring
• Expand the horizons of precision medicine for personalized patient care

Unleash the potential of cfDNA and transform clinical practice with Cell-Free DNA Blood Collection Tubes.

Cell-Free DNA Blood Collection Tubes: Revolutionizing cfDNA Stability and Sample Integrity for Precision Medicine

In the realm of precision medicine, cell-free DNA (cfDNA) has emerged as a transformative biomarker, offering a non-invasive window into the molecular landscape of disease. Circulating in the bloodstream, cfDNA fragments shed from tumor cells and other tissues hold invaluable diagnostic and prognostic information.

To effectively capture and preserve the integrity of these critical cfDNA molecules, Cell-Free DNA Blood Collection Tubes are meticulously designed with a unique formulation of anticoagulant and preservative reagents. This innovative solution ensures the stability of cfDNA for up to seven days at room temperature, eliminating the need for refrigeration and simplifying sample handling and logistics.

Key Features and Benefits:

• Unparalleled cfDNA Stability: The proprietary anticoagulant and preservative solution effectively stabilizes cfDNA molecules, preventing degradation and ensuring their availability for downstream analyses.
• Prevention of Genomic DNA Contamination: The tubes' unique formulation prevents the release of genomic DNA from cells, preserving the purity of cfDNA samples and eliminating the risk of contamination.
• Double-Coded Label Design: Each tube features a double-coded label design, ensuring accurate identification and traceability of samples throughout the processing workflow, minimizing the risk of errors.

Empowering Precision Medicine Advancements:

Cell-Free DNA Blood Collection Tubes play a pivotal role in advancing precision medicine by providing a reliable and efficient means of capturing and preserving cfDNA. Their unique features enable researchers and clinicians to:

• Detect and monitor cancer at its early stages: CfDNA analysis can provide early detection of cancer, facilitating timely interventions and improved patient outcomes.
• Monitor disease progression and treatment efficacy: CfDNA can track disease progression, assess treatment response, and identify potential recurrence risk, guiding personalized treatment strategies.
• Stratify patient populations for optimal treatment: CfDNA profiling can help stratify patients based on molecular characteristics, ensuring the selection of the most effective treatment options for each individual.

Advancing Clinical Care through cfDNA:

Cell-Free DNA Blood Collection Tubes revolutionize cfDNA isolation and preservation, empowering precision medicine to reach new frontiers. By providing a stable source of high-quality cfDNA, these tubes contribute to the development of novel diagnostic tools and personalized treatment approaches, ultimately improving patient care and outcomes.

Unleash the Potential of cfDNA for Precision Medicine:

With Cell-Free DNA Blood Collection Tubes, you can:

• Capture and preserve cfDNA with unparalleled stability and prevent contamination
• Enable reliable downstream analyses for accurate disease detection and monitoring
• Drive the advancement of precision medicine for personalized patient care

Embrace the power of cfDNA and transform clinical practice with Cell-Free DNA Blood Collection Tubes.

Product Performance

 Superior Safeguarding Against the Release of Blood Cellular DNA

Super NGS Library Yield and Quality

The blood samples were collected into Ardent BCT and conventional EDTA BCT. After being placed at room temperature for 5 days, the fragment size and peak pattern of free DNA were detected by a bioanalyzer. It can be seen that conventional EDTA BCT cannot prevent cfDNA degradation

Sequencing Fig. The read length of the NGS library of conventional EDTA BCT is shorter than that of Ardent BCT. Ardent BCT can better preserve free DNA and obtain high-quality libraries

High NGS Sequencing Quality